All Bookmarks

Working Group on New TB Drugs website

The mission of the New TB Drugs group is to accelerate the discovery and development of new drugs for the treatment of tuberculosis by bringing together the stakeholders in TB Drug Development, including the patients themselves.
The site features blogs, clinical research sites, upcoming meetings, grant opportunities, and resources.

Saved once (save to my bookmarks)
Bookmarked by The Editorial Team on 14 Feb 2012
0 points

Ethical issues of CRTs.

This site is primarily led by Charles Weijer at UWO.

Saved once (save to my bookmarks)
Bookmarked by The Editorial Team on 14 Feb 2012
0 points

Nuffield Council on Bioethics public lecture 2012

Are global health policies good for public health in developing countries?
Dr Amar Jesani

Editor of the Indian Journal of Medical Ethics, and Faculty, Centre for Studies in Ethics and Rights (Anusandhan Trust), Mumbai, India

Wednesday 16 May 2012, 17:30-21:00
Wellcome Collection, 183 Euston Road, London NW1 2BE

RSVP

This event is open to all and free to attend but please book your place in advance.

Contact: Johanna White

jwhite@nuffieldbioethics.org
+44 (0)207 681 9619

Lecture synopsis

Global health policies are shaped by multiple institutions, not all of them working directly in the field of health. These institutions both co-operate and compete with each other. But the dominant ones among them share some common approaches: (a) applying the principles of liberal economics to public health; (b) favouring certain technological and managerial solutions in system reforms; and (c) above all, having a common epistemological view on science and on what constitutes evidence. The dominance of this political, ideological and intellectual framework facilitates the opening up of public health to the market, and connects it to national and international corporate interests. In his lecture, Amar Jesani will argue that these developments are in conflict with people’s aspirations for more equitable socio-economic development, and for universal access to health care in developing countries. He will use India as a case study to demonstrate these points.

Saved once (save to my bookmarks)
Bookmarked by Editorial Team on 18 Apr 2012
0 points

NIH/International AIDS Society Grant Initiative

The applications can focus on any area of science including bioethics research related to HIV/AIDS.

The OAR and NIH–sponsored Centers for AIDS Research (CFARs), in collaboration with the International AIDS Society (IAS), are sponsoring a special research initiative targeting early-stage and junior level scientists who are not currently involved in AIDS research to consider applying their expertise to some aspect of AIDS-related research. This program will provide funding to non-Federal Government employees for creative and novel AIDS research projects. Projects selected for funding would be provided up to $150,000 (direct costs) plus applicable indirect costs per year for 1-2 years.

The announcement for this initiative is provided below. The Request for applications for this initiative can be accessed on www.cnihr.org <http://www.cnihr.org> . We would appreciate your providing this to your colleagues who are responsible for research and training programs and portfolios outside of AIDS research. Thank you for your cooperation and assistance.

Saved once (save to my bookmarks)
Bookmarked by dbogecho on 4 Jul 2011
0 points

HandsOn: Biobanks

HandsOn: Biobanks

Uppsala Konsert & Kongress
20-21 September 2012, Uppsala, Sweden

Biobanking has become hot, and rather quickly. The technology, the claims and the investments are increasing, but what is the value we are chasing? The route from a human biological sample and registry data to real benefit for patients and public health is complex. Many activities make up this route: funding, ethical review, sample and data collection, storage, bioanalysis and bioinformatics. Each is intended to add value, but how do we make sure we see and increase the benefits?

At this interactive conference we invite you to help understand and improve the activities in these value chains and bring more benefit to humanity. We will use Idea Labs, Hands-On Exhibitions, poster presentations and knowledge sharing to present, discuss and develop ideas for getting the best out of biobanking. We invite academy, industry, doctors, patient groups, policy makers, public representatives and legislators to share knowledge and concerns, and to contribute.

Saved once (save to my bookmarks)
Bookmarked by dbogecho on 13 Feb 2012
0 points